Anavex Life Sciences
AVXL
#9652
Rank
A$0.16 B
Marketcap
A$1.76
Share price
6.09%
Change (1 day)
-82.36%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -A$19.48 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$57.75 Million, an increase over its 2024 earnings that were of -A$74.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$19.48 Million-66.28%
2025 -A$57.75 Million-22.43%
2024 -A$74.44 Million14.77%
2023 -A$64.87 Million-17.49%
2022 -A$78.61 Million22.96%
2021 -A$63.93 Million35.36%
2020 -A$47.23 Million12.65%
2019 -A$41.93 Million29.09%
2018 -A$32.48 Million36.33%
2017 -A$23.83 Million17.11%
2016 -A$20.35 Million20.91%
2015 -A$16.83 Million-6.29%
2014 -A$17.96 Million337.28%
2013 -A$4.11 Million
2008 -A$7.6 Million106.01%
2007 -A$3.69 Million8848.98%
2006 -A$0.05 Million-79.99%
2005 -A$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.35 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$9.24 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$9.02 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.56 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA